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Abstract
Most starter cultures belong to the lactic acid bacteria group (LAB) and recognized as 
safe by the US Food and Drug Administration (FDA) and the European Food Safety 
Authority (EFSA). However, LAB may act as intrinsic or extrinsic reservoirs for antibiotic 
resistance (AR) genes. This fact may not constitute a safety concern itself, as the resistance 
gene transfer is vertical. Nevertheless, external genetic elements may induce changes that 
favor the horizontal transfer transmission of resistance from pathogens as well as from 
the human intestinal microbiota, which represents a severe safety issue. Some genus of 
AR LAB includes Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, and 
Streptococcus isolated from fermented meat and milk products. Currently, the WHO rec-
ommends that LAB used in the food industry should be free of resistance. Therefore, the 
objective of this chapter is to present an overview of the LAB antibiotic resistance and 
some methods to determine the same.
Keywords: lactic acid bacteria, antibiotic resistance transfer, extrinsic genes,  
QPS strains, and GRAS
1. Introduction
The antimicrobial resistance has become one of the main safety issues for humanity, and sev-
eral organizations, such as the World Health Organization (WHO), the Food and Agriculture 
Organization (FAO), the US Food and Drug Administration (FDA), and the European Food 
Safety Authority (EFSA) among others, have raised an awareness on this issue. The antimicro-
bial resistance can take place when microorganisms (bacteria, fungi, viruses, and parasites) 
are continuously exposed to antimicrobials (antibiotics, antivirals, antifungals, etc.), and as a 
result of an adaptation process, some microorganisms can survive and grow in the presence 
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of the antimicrobial, which in normal conditions would inactivate them [1, 2]. In particular, 
antibiotics are drugs used to treat bacterial infections in humans and animals, preventing the 
reproduction of bacteria or inactivating them through several mechanisms (Table 1), either 
inhibiting the synthesis of the cell wall or the cytoplasmic membrane, blocking the protein 
synthesis or the DNA copying processes, altering the metabolism, or acting directly against 
the bacterial resistance pathway [3–5]. The use of antibiotics in humans (cephalosporins, 
broad-spectrum penicillins, and fluoroquinolones) has increased 36% from the years 2000 to 
2010, mainly due to their inappropriate prescription and consumption for the treatment of 
viral instead of bacterial infections [3, 6]. This fact may be correlated with the global report 
on antimicrobial resistance that points over 700,000 human deaths each year associated to 
antimicrobial resistance, with a raising scenery to 10 million deaths each year by 2050 [2, 7].
The antimicrobial resistance involves several mechanisms associated to the presence of resis-
tant genes that allow the direct inactivation of the active antimicrobial molecule as well as the 
loss of susceptibility to the antimicrobial by modification of the target site or reduction of the 
antimicrobial uptake [6]. Therefore, antimicrobials become ineffective, and resistant micro-
organisms can survive and transfer their resistant machinery to other microorganisms and 
Table 1. Antibiotics: Site and mode of action [3–5].
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become a threat to public health [1]. The presence of antimicrobial-resistant microorganisms 
not only affects both the human and animal health but also increases the risk for spread and 
contamination of foods, crops, livestock, and aquaculture [3].
In particular, the FAO claims that 27 different antimicrobial classes are being frequently used 
in animals without an accurate reporting system to collect data related to their use and con-
trol [2]. Therefore, the WHO partners initiated a campaign all around the world in 2017, to 
raise the awareness of the antimicrobial resistance as part of a global program [1, 2]. The 
campaign constitutes a global action that involves governments, health professionals, food 
and feed industrialists, and the society to learn about antibiotic and antimicrobial resistance. 
It also includes some guidelines for the prevention and control of resistant Enterobacteriaceae, 
Acinetobacter, and Pseudomonads in health-care facilities. Additionally, the WHO recommends 
to farmers and the food industry sector to stop using antibiotics in healthy animals, in order to 
preserve the effectiveness of antibiotics currently used in human medicine [1–3, 8]. The global 
action plan on antimicrobial resistance points out that this issue has become an increasingly 
serious threat to public health and to the sustainable food production, where a rapid and 
effective response should involve the society and governments, as well as the health, food, 
and agriculture sectors and environmental specialists to promote practices that avoid the 
spread of antimicrobial resistance among common pathogens, especially those responsible 
for nosocomial and common infections [1, 2, 8].
The growing world population results in an increased demand for food, where antimicrobials 
such as antibiotics and fungicides are frequently used to treat infections in food-producing 
animals (cattle, swine, poultry, and fish), as well as in crops, to prevent diseases and as growth 
promoters [3]. This practice is frequently seen in developing countries where unauthorized 
high amounts of antibiotics are used that have been associated to the occurrence of multiple 
antibiotic-resistant Enterococcus and Lactobacillus strains from Indian poultry [2, 3, 9]. The FAO 
also reports that 90% of antibiotics may be excreted into the water and soil thus contaminating 
the environment, with the consequent exposure increment and development of AR microor-
ganisms that can transfer their resistant genes to other microorganisms [2]. For instance, bac-
terial populations from the intestine of animals exposed to antibiotics (tetracycline, penicillin, 
sulfonamide, and polymyxins) were five times more likely to be resistant [6]. The resistant 
microorganisms can be spread to humans from contaminated foods and water or from the 
environment [2, 3]. Various practices such as adequate animal vaccination and the use of 
additives that promote health and efficiency of feed conversion, in combination with good 
hygiene and husbandry practices would reduce the need for antimicrobials and antibiotics 
for food production [7, 8].
Lactic acid bacteria (LAB) constitute one of the most important groups of microorganisms 
present in several habitats; they are in large numbers in the gastrointestinal tract of animals 
and humans and form part of the microbiota in several foods. Historically, LAB have been rec-
ognized as safe with a GRAS (generally recognized as safe) and QPS (qualified presumption of 
safety) status given by the FDA and EFSA authorities. However, the recent detection of anti-
biotic-resistant LAB and the continuous exposure to environmental conditions may promote 
that LAB became as intrinsic or extrinsic reservoirs for AR genes, which can be horizontally 
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transmissible to pathogens through the food chain [3, 6]. The resistance to a specific antimicro-
bial may be intrinsic (when a microorganism does not possess target sites for the antimicrobial) 
or acquired. The acquired resistance is more complex and involves the presence of enzymes 
that inactivate the antimicrobial, posttranscriptional, or posttranslational modifications of the 
target site or reduction uptake and active efflux of the antimicrobial; those mechanisms derive 
from the gain of exogenous DNA or the mutation of indigenous DNA [4, 9, 10]. In general the 
AR genes can be horizontally transferred from one microorganism to another by transduction 
(via bacteriophages) or by transformation between microorganisms (when released DNA is 
taken up by other microorganism). However, it is claimed that the primary mechanism to 
acquire resistant is by direct cell to cell contact or conjugation between different genera of 
bacteria, especially when the resistant genes are present on mobile genetic elements such as 
plasmids and transposons [5, 10, 11]. LAB are highly adaptable and capable of developing 
resistance to antibiotics; most AR studies were focused on pathogenic microorganisms, but 
recently some investigators have questioned the safety of commensal LAB as some strains of 
Lactococcus lactis, Enterococci, and Lactobacillus isolated from fermented foods showed genes 
conferring resistance to tetracycline, erythromycin, and vancomycin [12].
Bacterial resistance to antibiotics is an emerging public concern that may compromise the 
efficacy of agents used for the treatment of infectious diseases [13]. Therefore, the objective of 
this chapter is to present an overview of the LAB antibiotic resistance and some methods to 
determine this characteristic, as per the FAO/OMS guideline for testing food-related bacteria 
and probiotics for resistance patterns.
2. Lactic acid bacteria
The term lactic acid bacteria refers to a taxonomically diverse group of Gram-positive bacte-
ria, facultative anaerobic, nonspore-forming, nonmotile, and acid-tolerant cocci, coccobacilli, 
or rods that appear as single cells or forming couples, tetrads, or long chains, with common 
metabolism and physiology capable of fermenting sugars primarily into lactic acid. LAB 
species are found in two phyla, the Firmicutes and the Actinobacteria; for the first the genus, 
Aerococcus, Alloiococcus, Carnobacterium, Enterococcus, Lactobacillus, Leuconostoc, Oenococcus, 
Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, and Weissella that are low G + C (31–49%) 
belong to the Bacilli class and the Lactobacillales order. While, the Bifidobacterium genus with a 
high G + C content (58–61%) belongs to the Actinobacteria phylum [6, 14, 15].
This bacterial group is classified into homofermentative and heterofermentative according 
to the end products derived from the glucose metabolism. The homofermentative converts 
glucose mainly into lactic acid by the Embden-Meyerhof pathway, while the heterofermenta-
tive LAB transforms glucose into lactic acid, carbon dioxide, and ethanol or acetic acid by the 
6-phosphogluconate pathway. LAB are capable of inhibiting the growth of spoilage and patho-
genic bacteria based on the competition for nutrients and adhesion niches due to their great 
acid tolerance and ability to adapt to redox changes [14, 15]. In addition LAB are capable to 
produce antimicrobial metabolites such as lactic and acetic acids, ethanol, hydrogen peroxide, 
diacetyl, antifungals (short-chain fatty acids derived from lipolysis reactions), antimicrobial 
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peptides known as bacteriocins, and other antibacterial proteins like peptidoglycan hydrolases 
(PGH) capable to cleave the peptidoglycan cell wall of Gram-positive and Gram-negative bac-
teria [6, 14]. Bacteriocins are ribosomal antimicrobial peptides active against closely related 
and non-related sensitive bacterial strains by forming pores in the cytoplasmic membrane and 
responsible for the reduction of microbial LAB competitors under stress conditions. Several 
studies have demonstrated the potential of bacteriocins to be applied for food preservation 
and in the pharmaceutical industry for their action against spoilage microorganisms and 
pathogens such Listeria monocytogenes and Staphylococcus aureus [16–18].
LAB have been safely used for centuries in numerous indigenous food fermentations up to 
the actual modern industry in the elaboration processes for dairy products, vegetables, meats, 
coffee, cocoa, silages, sourdough bread, and wine, as LAB contribute to the taste, flavor, and 
texture of those fermented products but also inhibit the development of spoilage and patho-
genic microorganism by acidification and production of antimicrobials [14, 19]. Therefore, 
LAB are widely employed as starter cultures in the food industry to accelerate ripening or 
to control the adventitious microbiota for elaboration and preservation of several fermented 
foods including dairy (hard- and semihard-type cheeses, yogurt, butter, and cream), meats, 
sourdough bread, and vegetables. LAB contribute to the taste, flavor, and texture of those fer-
mented products as a result of several reactions, including lipolysis, proteolysis, and conver-
sion of lactose in citrate and pyruvate intermediates that can be converted to various aromatic 
compounds, such as diacetyl, acetoin, acetaldehyde, and acetic acid. Proteolytic processes 
induces the accumulation of small peptides and free amino acids that are further transformed 
into alcohols, aldehydes, acids, and esters responsible for the flavor profile and organoleptic 
characteristics of fermented foods [14]. In addition some LAB strains such as Lactococcus lactis, 
Lactobacillus sakei, Lactobacillus rhamnosus, Lactobacillus helveticus, and Streptococcus thermophilus 
can produce exopolysaccharides (EPS) that not only confer protection to the cell producer but 
can be applied in the food industry as thickeners to increase viscosity and firmness, improv-
ing texture and mouthfeel of yogurt and other low-fat milk products. The EPS produced by 
LAB range from 10 to >2000 kDa and can be classified as homo- or heteropolysaccharides 
according to their monomer composition, where galactose, glucose, and rhamnose are the 
most common monomers [20].
Some LAB are present in the respiratory, gastrointestinal, and genital tracts of humans and 
animals and therefore used as probiotics for healthiness improvement related to their influence 
on the immune system for the prevention and control of some infections during pregnancy 
or as part of the treatment for antibiotic-derived diarrhea, constipation, and intestinal inflam-
mation, also to manage allergies and lactose intolerance and prevention of urinary infections 
[21–23]. The WHO and FAO describe the probiotics as live microorganisms that in adequate 
amounts confer health benefits for the host [24]. Several strains of Lactoccocus, Lactobacillus, 
Streptococcus, Enterococcus, Bifidobacterium, Pediococcus, and Propionibacteria present in foods and 
in dietary supplements are commonly used as probiotics and considered desirable members of 
the intestinal microbiota that can be used to deliver vaccines and other metabolites directly in 
the gastrointestinal tract [21]. Consumption of LAB probiotics may help for modulation of the 
immune system and reduction of pathogens, thereby, improving the gut functionality. Other 
health benefits associated to the consumption of LAB probiotics include an antihypertensive 
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effect, reduction in the serum cholesterol level, antioxidant effect, protection against colon can-
cer, reduction in the allergy symptoms, reduction in dental caries, and reduction in the obesity 
index [21, 22]. In addition, secondary metabolites with health-promoting properties include the 
antihypertensive angiotensin-converting enzyme produced through the proteolytic system of 
Lactobacillus helveticus, Lactobacillus acidophilus, and Lactobacillus delbrueckii [14, 22].
LAB are considered naturally resistant to several antibiotics and may have the potential 
to acquire resistance to other antimicrobials or to disseminate the resistance to pathogens 
present in the gastrointestinal tract of animals and humans [9]. For instance, Shao et al. [11] 
demonstrated that two isolates of L. plantarum possessed the aaadA and ant(6) genes associ-
ated to the resistance to streptomycin, and the overexposure to this antibiotic dramatically 
increased the minimum inhibitory concentration (MIC) and increased a cross-resistance to 
other antibiotics from the same class. On the other hand, the presence of 6% strains isolated 
from some pharmaceutical and dairy products from Egypt with tetracycline [tet(M)] and/
or erythromycin [erm(B)] resistant genes has been reported [21]. In a similar study, a high 
incidence of Lactobacillus resistant to vancomycin (58%), erythromycin (10.8%), tetracycline 
(4.3%), gentamicin (48%), and ciprofloxacin (26%) was reported in Turkish fermented dairy 
products [13]. However, studies made by Flores and Mayo [25] indicate that no transfer of 
the tetracycline [tet(M)] and erythromycin [erm(B)] resistant genes from S. thermophilus to L. 
delbrueckii was detected during the production and storage of yogurt. Furthermore, the food 
chain can facilitate the transmission of antibiotic-resistant bacteria between animals, foods, 
and humans, being the fermented milk and meat products the most common vehicle for 
antibiotic-resistant bacteria to the indigenous flora of the gastrointestinal tract, as these prod-
ucts are consumed without a thermal treatment [12]. Even though that some reports confirm 
the transmission of resistant determinants, the two most common resistant genes in LAB are 
tetracycline [tet(M)] and erithromycin [erm(B)] resistant genes, followed by cat genes coding 
for chloramphenicol resistance [26]. Considering the wide range of potential applications of 
LAB in the industry and in the human and animal health, there is a need of their detailed 
examination that involves the detection of AR genes.
3. Transfer mechanisms of antibiotic resistance genes
For antibiotics to function and inhibit microbial growth, they must be at the proper concen-
tration so that they can cross the cellular wall and interact with their target. As previously 
mentioned, AR is the capacity that has a microorganism to resist the inhibitory activity of an 
antibiotic beyond the normal susceptibility of similar bacterial species [27]. On the other hand, 
the different mechanisms of AR are based on the modification of the antibiotic target site as 
well as on the reduction of the antibiotic concentration that manages to get the cell target.
LAB are considered carriers of resistance genes that could propagate their genes within the 
food chain between food and humans, as well as to the environment through different mecha-
nisms [27–30]. According to the FAO and WHO [24], it is important to determine whether 
starter or probiotic cultures intended for human or animal consumption have mobile resistance 
genes that could be transferred to other microorganisms [6, 31]. In addition, some authors have 
demonstrated that the use of antibiotics in animals destined for consumption, either as growth 
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promoters or pathogen inhibitors, is directly related to the presence of AR microbiota in the 
human gastrointestinal tract [27, 32]. On the other hand, Gad et al. [21] isolated some Lactobacillus, 
Streptococcus, and Lactococcus strains from both pharmaceutical and probiotic dairy products, 
but the AR tests from the pharmaceutical probiotic isolates were free of resistance genes, unlike 
the LAB isolated from dairy products that showed resistance profiles comparable to those from 
pathogens such as Staphylococcus spp., Escherichia coli, and Salmonella spp. Furthermore, some 
Enterococcus faecium strains have demonstrated the transference of vancomycin resistant genes 
from to Lactobacillus acidophilus La5 “in vitro” and “in vivo” studies in the gut mice [33].
Exposure to antibiotics may allow bacteria to develop different mechanisms to counteract the 
bactericidal effect; a single bacterium can develop different types of resistance; these systems 
include an intrinsic or innate and the acquired resistance mode. Among these, the mechanism 
that prevails within bacteria varies according to the nature of the antibiotic, the target site, 
the bacterial species, and/or whether the resistance gene is part of the chromosome or mobile 
elements such as plasmids or transposons [12, 19, 28].
3.1. Mechanisms of resistance in LAB
Two relevant elements must be present for the antibiotic-target interaction, first the antibiotic 
must recognize the target, and the concentration of the antibiotic in the target must be suffi-
cient to inhibit the bacterial growth. A resistance mechanism conduces to the antibiotic failure 
to inhibit the bacterial growth due to an inefficient antibiotic-target interaction, which can be 
classified as passive and active. The passive mechanism can only be transferred to other cells 
by clonal transfer that involves modifications of the target site or decrease in antimicrobial 
absorption, without affecting the antibiotic structure; this resistance is also known as intrinsic 
resistance. In contrast, the active mechanism involves the reduction on the concentration of 
the intracellular antibiotic by modification or degradation of its structure with enzymes or 
through the action of efflux pumps [34, 35].
Figure 1 shows the mechanisms by which some bacteria can show resistance to antibiot-
ics that involves (1) modification of the antibiotic by enzymatic complexes that prevent the 
antibiotic-target interaction, (2) enzymatic degradation of intra- or extracellular antibiotics, 
and (3) reduction in the intracellular antibiotic concentration through the activation of flow 
pumps or due to the change in the cell wall permeability [19].
The main mechanism of resistance to antibiotics presented by LAB has been related with 
multidrug-resistant (MDR) efflux pumps involved in the expulsion of structurally unrelated 
compounds [31, 36]. Wacher-Rodarte et al. [37] analyzed LAB isolated from pozol (a tradi-
tional fermented maize beverage), identifying that MDR strains such as Lactococcus lactis and 
Lactobacillus plantarum present active efflux pumps, including the chromosomally encoded 
ABC type with the LmrA transporter (lmrA gene). On the other hand, Poelarends et al. [38] 
demonstrated that the presence of the LmrA transporter in Lactococcus lactis is associated 
with the innate resistance of 17 up to 21 clinically relevant antibiotics, including aminoglyco-
sides (kanamycin and gentamicin), lincosamines (clindamycin), macrolides (erythromycin), 
quinolones (ciprofloxacin), and tetracyclines. Other authors such as Casado Muñoz et al. 
[39] reported that Lactobacillus pentosus and Leuconostoc pseudomesenteroides isolated from 
fermented olives are resistant to cephalosporins, streptomycin, and kanamycin due to the 
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variation of the cell wall permeability as their main mechanism of resistance; they also pointed 
that both strains presented a complex AcrAB-TolC system involved in MDR efflux pumps 
for β-lactams, fluoroquinolones, chloramphenicol, tetracycline, and other genes related with 
chromosomally encoded superfamily pumps norA and Mde that confer resistance to chloram-
phenicol and fluoroquinolones.
The resistance to aminoglycosides in LAB has not been reported, although in recent years 
LAB isolated from farm origin show resistant to gentamicin, kanamycin, and streptomycin, 
whose resistance mechanism is associated to impaired transport or enzymatic inactivation 
by three main aminoglycoside-modifying enzymes (AMEs) as N-acetyltransferases (AACs), 
O-phosphotransferases (APHs), and O-nucleotidyltransferases (ANTs) encoded by MGEs 
(mobile genetic elements) like transposons and insertion sequences [40].
Some bacteria belonging to the genera Enterococcus, Lactobacillus, Pediococcus, and Bifidobacterium 
present both intrinsic or innate and extrinsic or acquired AR, which can be a factor of food 
safety as they can spread resistance to other bacteria by vertical (between species) or horizon-
tal transference (between bacterial genera) [25, 29, 31, 41].
3.1.1. Intrinsic resistance
Intrinsic resistance is the natural or innate ability of a bacterium to survive the effect of anti-
biotics, as a result of mutations derived from changes in the bacterial physiological state or 
by the uncontrolled exposure to antibiotics [42]. Intrinsic resistance has a minimum propaga-
tion potential between bacterial genera, as resistance genes are located into the chromosome 
with a limited transference to other genus, which represents a low risk within nonpathogenic 
bacteria. Any gene responsible for intrinsic resistance could be disseminated and transferred 
to other bacteria if it is flanked by insertion sequences that may promote its mobilization [12]. 
For instance, Bifidobacterium strains are commonly used as starter cultures and/or prebiotics 
Figure 1. Mechanisms of antibiotic resistance in the LAB: (1) enzymatic modification, (2) enzymatic degradation, and (3) 
enzyme efflux pumps. Adapted from Sharma et al. [19].
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in traditional and industrialized fermented foods although they have intrinsic resistance to 
quinolones (ciprofloxacin and nalidixic acid), mupirocin, tetracyclines, and aminoglycosides 
such as streptomycin; however, all the genes are located in the chromosome with a limited 
transference to other genus [28, 43]. It has been reported that some LAB genera have intrin-
sic resistance to bacitracin, vancomycin, kanamycin, teicoplanin, and quinolones [28]. This 
intrinsic resistance mechanisms presented by LAB include:
• Modification of the cell wall, commonly observed in the resistance to glycopeptides 
(vancomycin and teicoplanin) and non-ribosomal antibiotics (bacitracin). In particular, 
Lactobacillus plantarum and Enterococcus faecium present innate resistance to vancomycin, 
due to the substitution of D-alanine residues of the muramyl pentapeptide cell wall by 
D-lactate (high-level resistance) or D-serine (low-level resistance) in the chemical structure 
of the peptidoglycan, thus avoiding the antibiotic interaction [35, 41, 44].
• Enzymatic inactivation such as for aminoglycosides (neomycin, kanamycin, streptomycin) 
or quinolones (ciprofloxacin, norfloxacin, nalidixic acid) prevents the binding of these anti-
biotics with their specific targets, as observed for Lactobacillus and Enterococcus for the 16S 
rRNA of the 30S ribosomal bacterial subunit and DNA gyrase, respectively, that explains 
the intrinsic resistance to both groups of antibiotics [29, 40].
3.1.2. Extrinsic resistance
Extrinsic or acquired resistance is one in which bacteria can incorporate into their cellular 
structure mobile genetic material capable of conferring resistance to certain antibiotics. Unlike 
intrinsic resistance, the acquired resistance is only found in some traits or bacterial subpopu-
lations. The gene propagation may occur between bacteria of different genera or between 
different organisms. The horizontal gene transfer (HGT) occurs when the bacteria is capable 
of acquiring new genes that can increase their intrinsic resistance spectrum, or they can trans-
fer resistance to other microorganisms or directly to humans or animals, which is already 
considered a health risk, according to the WHO. Therefore, the protocols for the analysis of 
resistance genes in LAB are increasing as they have a high capacity to acquire AR and since 
they have a close relationship with food processing [6, 19, 31, 45, 46]. Figure 2 shows the 
three main mechanisms of HGT; some of which are not considered relevant in the transfer 
of resistance to antibiotics in LAB, for example, transduction (through bacteriophages) and 
transformation (when DNA is released from one bacterium and is absorbed by another), as 
the conjugation is the primary mechanism observed in lactic acid bacteria [12, 19, 47, 48].
The conjugation is the transfer of mobile genetic material from plasmids or transposons 
through a tube of proteins, called sexual pilus [6]. Plasmids are extrachromosomal DNA 
molecules capable of autonomous replication and that may confer resistance to microorgan-
isms against antibiotics and represent one of the main mobile elements for dissemination of 
antibiotic-resistant genes against β-lactams, aminoglycosides, tetracyclines, chloramphenicol, 
sulfonamides, trimethoprim, macrolides, and quinolones [29, 47, 48].
Plasmids have a large number of genetic determinants that may confer resistance by conjuga-
tion, and it is important to consider that a single bacterium can have multiple plasmids [49]. 
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Some authors indicate that the genetic diversity of resistance is proportional to the number of 
plasmids present in the environment, without forgetting that there are other mobile elements 
such as transposons and integrons, although these elements do not self-replicate and must be 
transported by an appropriate plasmid or phage [49, 50]. Some conjugative transposons used 
as vehicle of antibiotic resistance genes in LAB include Tn916, Tn918, Tn920, Tn925, Tn2702 
(E. faecalis), Tn5233 (E. faecium), Tn5276, and Tn5301 (Lactococcus lactis) [19].
3.2. Resistance to antibiotics in LAB
As mentioned, the presence of resistance genes in LAB is considered a public health problem, 
so the EFSA through the panel of additives and products or substances used in animal feed 
(FEEDAP) developed a technical guide to identify the bacteria that show acquired resistance 
to antibiotics such as ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythro-
mycin, clindamycin, tetracyclines, and chloramphenicol [51]. Most LAB that present acquired 
resistance in the food production chain include the obligate homofermentative Lactobacillus gen-
era (L. helveticus, L. acidophilus, L. delbrueckii), obligate heterofermentative Lactobacillus (L. reuteri, 
L. fermentum), heterofermentative Lactobacillus facultative (L. plantarum, L. rhamnosus, L. paracasei), 
Lactococcus lactis, Streptococcus thermophilus, Pediococcus spp., Leuconostoc spp., and Enterococcus 
spp. [31, 51]. On the other hand, LAB can be incorporated into food in the form of probiotic or 
starter cultures or they can be part of the natural microbiota of traditional fermented foods, but 
some authors have found that the vast majority of these bacteria are resistant to antibiotics [6, 
19, 31, 40, 45]. Table 2 shows some AR LAB isolated from traditional fermented foods, indus-
trialized and probiotic recommended for improving the intestinal microbiota [20, 37, 49, 50]. 
Figure 2. Mechanisms of horizontal gene transfer in the LAB. (1) conjugation is a process requiring the cell to cell contact 
via cell surface pili; (2) cell transformation by integrating extracellular DNA; (3) transduction, bacteriophages may 
transfer bacterial DNA from a previously infected donor cell to the recipient cell. Adapted from Sharma et al. [19] and 
Von Wintersdorff et al. [47].
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In particular, the enterococcal and Lactobacillus genera may be associated to a health risk, as 
they carry innate and acquired resistance genes and because of their high residence in food and 
in the gastrointestinal microbiome of humans and animals [28, 36].
3.2.1. Enterococcus
Enterococci are widely distributed in vegetables, dairy products, prepared foods, and meat prod-
ucts and used as probiotics; however, they have intrinsic resistance to a large number of antibiot-
ics such as β-lactams and aminoglycosides. In some cases, they can present profiles of resistance 
similar to enterococci considered nosocomial emergent pathogens which could present multiple 
drug resistance (MDR) with mechanisms of resistance that include modification of pharmacolog-
ical targets, inactivation of therapeutic agents, overexpression of efflux pumps, and sophisticated 
adaptive response of cell envelope that promotes survival in the human host [41, 52].
Table 2. Lactic acid bacteria resistant to antibiotics isolated from food [20, 37, 49, 50].
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Streptomycin was the first aminoglycoside reported for which resistance appeared in enterococ-
cal strains (concentrations higher than 2000 μg/mL); this resistance is carried out by adenylation of 
streptomycin, by the action of the enzyme streptomycin adenyltransferase, encoded by the aadA 
gene [35, 41]. Resistance to gentamicin, kanamycin, neomycin, and netilmicin (aminoglycosides 
as well) is mainly due to the production of the bifunctional enzyme 2′-phosphotransferase-6′-
acetyltransferase, which promotes the ATP-dependent phosphorylation of aminoglycosides [41].
Strains of enterococci of clinical origin between 60 and 65% exhibit resistance to tetracyclines, 
although these antibiotics are not routinely used in the treatment of infections caused by 
these microorganisms. There are two fundamental mechanisms of resistance to tetracyclines 
in enterococci: flow pumps and protection of the ribosome, thus preventing the binding of the 
antibiotic. The tetK and tetL genes code for proteins associated to flow pumps responsible to 
remove the antibiotic outside of the cell, while the tetM, tetO, and tetS genes code for proteins 
that provide resistance to tetracyclines for ribosome protection. The tetL and tetM genes are 
the most frequent in the chromosome and mobile determinants [41, 52, 53]. Finally, vanco-
mycin (glycopeptide) is the main cause of concern, since this antibiotic is considered at the 
last option for antibiotic therapy for the treatment of Gram-positive bacteria. The resistance 
to vancomycin in enterococci is varied, having described six genotypes called vanA, vanB, 
vanC, vanD, vanE, and vanG, where the genotype vanA is more frequent in the Enterococcus 
genus [41].
3.2.2. Lactobacillus
In general, Lactobacilli have a high natural resistance to vancomycin, bacitracin, cefoxitin, 
metronidazole, nitrofurantoin, and sulfadiazine, as well as antibiotics that inhibit the synthe-
sis of proteins such as chloramphenicol, erythromycin, quinupristin/dalfopristin, lincomycin, 
clindamycin, and tetracyclines [45]. Guo et al. [54] observed 85% of incidence of vancomy-
cin resistance in food isolated Lactobacillus strains, especially in Lactobacillus plantarum and 
Lactobacillus casei, with the lower frequency for Lactobacillus helveticus, but these resistances 
are not transferable, as genes are located in the chromosome [54]. In addition, genes that code 
for resistance to tetracycline and erythromycin have been detected in different Lactobacillus 
species isolated of probiotics and foods [12, 31, 55].
The genus Lactobacillus is an excellent receptor for exogenous genes by conjugation, as dem-
onstrated by Abriouel et al. [45] for the conjugative pAMβ1 plasmid found in Lactobacillus 
plantarum that could be obtained from enterococci and streptococci. Lactobacillus are commonly 
susceptible to antibiotics, such as penicillins (ampicillin, oxacillin, and piperacillin), inhibitors of 
β-lactamase, and cephalosporins (cephalothin and cefuroxime, ceftriaxone and cefoxitin), but in 
recent years some authors have reported resistance to penicillin G in some strains of Lactobacillus 
rhamnosus, Lactobacillus reuteri, and Lactobacillus plantarum [45, 56]. Other studies demonstrated 
that Lactobacillus rhamnosus is safe to use as a starter or probiotic culture, despite having resis-
tance genes to vancomycin, as these resistance is encoded into the chromosome [45, 48, 54].
3.3. Horizontal transfer of LAB to the intestinal microbiota
The horizontal gene transfer (HGT) involves the gene interchange between different bacteria 
through mobile DNA elements such as plasmids, conjugative transposons, integrons, and 
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bacteriophages [27, 47–49]. The transfer of resistance genes by HGT initiates from the farm ani-
mals that were treated with antibiotics used as growth promoters to prevent diseases, but these 
uncontrolled treatments may induce resistance in their intestinal microbiota; later this biota 
can reach foods and finally being transferred to the human [3]. Conjugation in food matrices 
has been reported from commensal bacterium (Enterococcus faecalis and Lactococcus lactis) to 
potentially pathogenic strains (Listeria spp., Salmonella spp., Staphylococcus aureus, and E. coli) in 
fermented milk [25, 27]. Also, the transfer of tetracycline resistance genes among LAB has been 
reported in fermented milk and fermented sausages [27]. Martínez and Baquero [34] report the 
HGT of tetracycline and vancomycin resistance genes in Enterococcus faecalis during the fermen-
tation process of cheese and sausages. Bonham et al. [30] have demonstrated that aged cheeses 
contain AR Lactobacillus and Lactococcus that acquired the resistance through HGT induced by 
the strong condition of microbial selection during the food production and maturation process.
A wide diversity of AR species can be found in the human gastrointestinal tract that could be 
acquired AR genes by HGT; this fact is related to the metagenomic comparison showing that 
most resistance genes found in the human microbiome are those associated with approved 
antibiotics used in livestock, which supported the hypothesis that resistance genes can be trans-
ferred from the farm to consumers [48]. Therefore, the WHO indicates that the HGT genes can 
be a significant health problem, as most antibiotic resistance is acquired through the HGT [1].
4. Regulation of the use of LAB
The FDA categorizes microorganisms with the GRAS distinction after being evaluated in 
general aspects of safety, taxonomy, potential to produce pathogenicity toxins, resistance to 
antibiotics, and the historical background of food safety. LAB have a broad history of use in 
fermented foods and usually recognized as safe. However, the dissemination of AR genes 
puts the GRAS category in another context, especially for bacteria that present mobile genes 
of transfer such as Lactobacillus, since in the US there are still no guidelines that contemplate 
the type of resistance in microorganism used in food processing [57]. On the other hand, 
the EU commission regulates the safety of LAB used as starter or probiotic cultures in the 
European continent, through the EFSA that establishes guidelines for assigning qualified pre-
sumption of safety quality to the organisms since 2003. As previously mentioned, the term 
QPS is based on reasonable and qualified evidence to allow certain restrictions and may be 
analogous to the GRAS concept but with more rigid guidelines in which the reliable safety 
of the bacteria is verified, making clear the phrase “from farm to fork” [58]. The QPS status 
is given to a bacterium, by the EFSA BIOHAZ Panel (Biological Hazards) that must take into 
account the following aspects (Figure 3): (1) the identity of the taxonomic unit at the genus 
level; (2) documentation related to the LAB safety, based on scientific evidence and history of 
use; (3) pathogenicity, in which it is evaluated if any species of the genus has pathogenicity 
factors, if the information is available, the pathogenic strains are excluded; and (4) knowledge 
of the final use of the microorganism, identifying if the bacteria is part of the food chain or if 
it is used to produce other products [6, 58].
The list of QPS includes species of Lactobacillus sakei, Lactobacillus curvatus, Lactobacillus 
plantarum, Lactobacillus fermentum, Lactobacillus brevis, Lactobacillus rhamnosus, Lactobacillus 
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alimentarius, Leuconostoc lactis, Leuconostoc citreum, Leuconostoc mesenteroides, Leuconostoc 
 pseudomesenteroides, Pediococcus acidilactici, Pediococcus dextrinicus, Pediococcus pentosaceus, 
Lactococcus lactis, and Streptococcus thermophilus [6]. In the case of Enterococcus, the QPS cat-
egory cannot be assigned to all species; each specie must be individually analyzed [6].
5. Methods to identify antibiotic-resistant LAB
Most widely used antibiotic susceptibility testing methods are based on (1) phenotypic 
detection of antibiotic resistance by measuring bacterial growth in the presence of the tested 
antibiotic and (2) molecular identification of resistant genotypes through polymerase chain 
reaction (PCR) [21, 25, 29, 39, 54]. The evaluation of phenotypic susceptibility to antibiotics in 
lactic acid bacteria should be done using recognized methods that allow the identification of 
the minimum inhibitory concentration (MIC) for the most commonly used antibiotics. Most 
LAB species used in food can be evaluated by the method described in ISO 10932: 2010 [59], 
considering the conditions and culture media for Bifidobacteria and LAB that do not belong to 
the genus enterococci [56, 57]. In case of having strains of Enterococcus, it is recommended to 
use the methods described by the Clinical and Laboratory Standards Institute [21, 60]. Some 
of the recommended methods to determine the MIC in LAB are the E-test, the Kirby-Bauer 
test (diffusion method), and the broth microdilution method (MDIL) [43]. In particular the 
cutoff values are known for the genera Lactobacillus, Pediococcus, Lactococcus, Streptococcus, and 
Bifidobacteria. The MDIL method is widely used to evaluate MIC for a large number of strains 
and antibiotics, although the method has some limitations, especially for those antibiotics 
for which a strain could quickly acquire resistance [43]. However, MIC evaluation in LAB 
is somewhat inconsistent among the researchers, mainly due to the lack of culture media 
that can ensure proper growth of LAB without interfering with the assay results. Therefore, 
Figure 3. Scheme for assessing the suitability for qualified presumption of safety (QPS) status of a BAL. adapted from 
Laulund et al. [58].
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a complementary technique involves the search for AR genes using PCR techniques and 
microarrays [25, 29, 54]. Also, identifying the location of these genes allows to determine their 
potential transfer, while their sequencing can provide evidence of their bacterial taxa and 
identity of the genes, which helps to trace the origin of their genomes [29].
Functional metagenomics is an important approach in the investigation of antibiotic resistance 
genes (ARG) since it can be used to identify and characterize new ARG, including those not pre-
viously associated with antibiotic resistance [48, 61]. It is also one of the most recent techniques 
in the study of resistance in pure bacterial groups or more complex samples such as food; some 
works reported in the literature indicate the wide diversity of resistance systems that are pres-
ent in food, considering the cultivable and not cultivable bacteria. Metagenomic studies help 
to understand the mechanisms of resistance in such a way that it allows direct applications in 
the identification of new drugs and the synthesis of novel and active antibiotic molecules [61].
5.1. Procedure to evaluate LAB resistant to antibiotic used in food
The FEEDAP Panel proposed a scheme to evaluate the resistance present in lactic acid bacteria 
that can be used as probiotic or starter cultures in food processing; as previously mentioned, it 
is essential to distinguish between the intrinsic and acquired resistance as part of the food safety 
of lactic acid bacteria [58, 62]. The correct identification of the bacteria (sequencing and com-
parison of the 16S rDNA gene in international databases) by molecular taxonomy is essential 
to evaluate the type of resistance, since the intrinsic resistance is specific for a specie or genus. 
Once the specie under study has been identified, the MIC (minimum inhibitory concentration) 
Figure 4. Proposed scheme for the antibiotic resistance assessment of lactic acid bacteria used as probiotic and starter 
culture. Adapted from Laulund et al. [58] and EFSA [62].
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in which the LAB is sensitive to the antibiotic analyzed is determined. The bacterium can 
be considered safe when the MIC is lower than the cutoff level (MIC < cutoff). On the other 
hand, if the MIC value is above the cutoff value (MIC > cutoff), the bacterium is considered 
resistant to the antibiotic, and its resistance should be confirmed by molecular methods as PCR 
[39, 54, 62]. However, the resistance genes not always are expressed but can be transferred to 
other bacteria if the environmental conditions stimulate the expression of these genes [34]. If 
the bacteria have intrinsic resistance, it is considered acceptable for use in food. Otherwise, it 
must be demonstrated whether the acquired resistance is in mobile genetic material or was 
acquired in the process of mutation in the bacterial chromosome (also acceptable for use in 
foods). Finally, the bacteria are not accepted by any regulatory body for its application in food 
if it is demonstrated that the resistance is exogenous and easily transferable (Figure 4).
6. Conclusion
LAB are of great importance in the food industry for the preparation of fermented foods, in 
addition to being widely used as probiotics to regulate the intestinal microbiota in animals 
and humans. However, it is important to carry out the appropriate tests to identify the pres-
ence of antibiotic resistance genes that can be transferred horizontally to other microorgan-
isms, whether pathogenic or those present in the gastrointestinal microbiota, which can cause 
a health problem because of the continuous exposure to the environmental conditions that 
favor the resistance spread that threats the public health and the food production.
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